Catalyst Wire Dossier Catalyst Wire Dossier

BEOVU

BROLUCIZUMAB · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

33 regulatory and trial events tracked for BEOVU, covering 2014-10-01 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema. [Phase 4]

See pricing